Electron Perturbation for Chiral DNA Point Mutation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40213973.
- Also identified by DOI 10.1021/acsnano.4c13148.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Advances in molecular nanotechnology have enabled the design of systems that exploit nanoscale interactions for enhanced biosensing and diagnostics. Here, we present a plasmonic nematic film (PNF) that leverages nanoscale plasmonic hotspots to amplify electron perturbations induced by DNA mutations. Sequence-specific mismatches, particularly point mutations, significantly alter the local electromagnetic environment, leading to distinct and quantifiable spectral shifts in circular dichroism (CD), denoted as Δλ<sub>dip</sub>. These shifts exhibit a strong correlation with target DNA concentration (<i>R</i><sup>2</sup> > 0.99), enabling precise, quantitative detection of mutation-induced asymmetry. The underlying mechanism is modeled by the asymmetric chiral signal <i>I</i><sub>asy</sub> = ∫Ψ<sub>PNF*</sub>(Ω)Ψ<sub>PNF</sub> d<i>V</i>, where Ψ<sub>PNF</sub> is the wave function of the PNF and Ω represents its chiroptical response. Simulations and electric field analysis further validate that mutation-driven perturbations at the PNF-DNA interface enhance local field intensity at λ<sub>dip</sub>, while no significant changes occur at nonresonant wavelengths. Through this mechanism, the PNF platform achieves over 240% enhancement in chiroptical signal compared to wild-type DNA and enables mutation detection down to 1534 pg. These findings highlight the system's potential for high-specificity diagnostics of clinically relevant mutations, including those associated with hereditary hearing impairment, and may inform the development of future chiral biosensing platforms.
Medical subject headings
- DNA
- Point Mutation
- Electrons